Literature DB >> 29766293

NMDA receptor subunits change in the prefrontal cortex of pure-opioid and multi-drug abusers: a post-mortem study.

Hamidreza Daneshparvar1, Mitra-Sadat Sadat-Shirazi2,3, Monir Fekri2, Solmaz Khalifeh4, Ali Ziaie5, Nasrin Esfahanizadeh6, Nasim Vousooghi2,3, Mohammad-Reza Zarrindast7,8.   

Abstract

Addiction is a chronic relapsing disorder and is one of the most important issues in the world. Changing the level of neurotransmitters and the activities of their receptors, play a major role in the pathophysiology of substance abuse disorders. It is well-established that N-methyl-D-aspartate receptors (NMDARs) play a significant role in the molecular basis of addiction. NMDAR has two obligatory GluN1 and two regionally localized GluN2 subunits. This study investigated changes in the protein level of GluN1, GluN2A, and GluN2B in the prefrontal cortex of drug abusers. The medial prefrontal cortex (mPFC), lateral prefrontal cortex (lPFC), and orbitofrontal cortex (OFC) were dissected from the brain of 101 drug addicts brains and were compared with the brains of non-addicts (N = 13). Western blotting technique was used to show the alteration in NMDAR subunits level. Data obtained using Western blotting technique showed a significant increase in the level of GluN1 and GluN2B, but not in GluN2A subunits in all the three regions (mPFC, lPFC, and OFC) of men whom suffered from addiction as compared to the appropriate controls. These findings showed a novel role for GluN1, GluN2B subunits, rather than the GluN2A subunit of NMDARs, in the pathophysiology of addiction and suggested their role in the drug-induced plasticity of NMDARs.

Entities:  

Keywords:  Addiction; N-Methyl-D-aspartate (NMDA) receptor; Opioid; Post-mortem; Prefrontal cortex

Mesh:

Substances:

Year:  2018        PMID: 29766293     DOI: 10.1007/s00406-018-0900-8

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  43 in total

Review 1.  Cellular mechanisms of neuropathic pain, morphine tolerance, and their interactions.

Authors:  D J Mayer; J Mao; J Holt; D D Price
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

Review 2.  The medial prefrontal cortex as a part of the brain reward system.

Authors:  T M Tzschentke
Journal:  Amino Acids       Date:  2000       Impact factor: 3.520

3.  The abuse of multiple drugs. I. Definition, classification, and extent of problem.

Authors:  E Kaufman
Journal:  Am J Drug Alcohol Abuse       Date:  1976       Impact factor: 3.829

Review 4.  Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex.

Authors:  Rita Z Goldstein; Nora D Volkow
Journal:  Am J Psychiatry       Date:  2002-10       Impact factor: 18.112

Review 5.  Glutamate as a neurotransmitter in the brain: review of physiology and pathology.

Authors:  B S Meldrum
Journal:  J Nutr       Date:  2000-04       Impact factor: 4.798

6.  History of the methamphetamine problem.

Authors:  M D Anglin; C Burke; B Perrochet; E Stamper; S Dawud-Noursi
Journal:  J Psychoactive Drugs       Date:  2000 Apr-Jun

7.  Chronic morphine treatment alters expression of N-methyl-D-aspartate receptor subunits in the extended amygdala.

Authors:  Michal Bajo; Elena F Crawford; Marisa Roberto; Samuel G Madamba; George Robert Siggins
Journal:  J Neurosci Res       Date:  2006-03       Impact factor: 4.164

8.  Prefrontal cortical volume reduction associated with frontal cortex function deficit in 6-week abstinent crack-cocaine dependent men.

Authors:  George Fein; Victoria Di Sclafani; Dieter J Meyerhoff
Journal:  Drug Alcohol Depend       Date:  2002-09-01       Impact factor: 4.492

9.  Region-specific changes in NMDA receptor mRNA induced by chronic morphine treatment are prevented by the co-administration of the competitive NMDA receptor antagonist LY274614.

Authors:  Hongbo Zhu; Marina Brodsky; A Laurel Gorman; Charles E Inturrisi
Journal:  Brain Res Mol Brain Res       Date:  2003-06-10

Review 10.  Associative processes in addiction and reward. The role of amygdala-ventral striatal subsystems.

Authors:  B J Everitt; J A Parkinson; M C Olmstead; M Arroyo; P Robledo; T W Robbins
Journal:  Ann N Y Acad Sci       Date:  1999-06-29       Impact factor: 5.691

View more
  3 in total

Review 1.  Mechanism of opioid addiction and its intervention therapy: Focusing on the reward circuitry and mu-opioid receptor.

Authors:  Jia-Jia Zhang; Chang-Geng Song; Ji-Min Dai; Ling Li; Xiang-Min Yang; Zhi-Nan Chen
Journal:  MedComm (2020)       Date:  2022-06-22

2.  Identification and Characterization of Biomarkers and Their Role in Opioid Addiction by Integrated Bioinformatics Analysis.

Authors:  Xiuning Zhang; Hailei Yu; Rui Bai; Chunling Ma
Journal:  Front Neurosci       Date:  2020-11-27       Impact factor: 4.677

Review 3.  Narcotic Addiction in Failed Back Surgery Syndrome.

Authors:  Yuan-Chuan Chen; Ching-Yi Lee; Shiu-Jau Chen
Journal:  Cell Transplant       Date:  2018-08-31       Impact factor: 4.064

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.